AI-ECG Platform vs Viz RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Carewell Health
VS
by Viz.ai

AI Verdict

Tool A, the AI-ECG Platform, focuses on AI-powered analysis and diagnosis of 12-lead resting ECGs for various cardiac conditions. In contrast, Tool B, Viz RV/LV, specializes in automating RV/LV ratio measurements from CTPA scans to stratify pulmonary embolism risk. While both are categorized as Cardiology AI and are relevant in Emergency Medicine, they utilize distinct input data and address different diagnostic pathways, making them complementary rather than direct competitors.

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your primary need is highly accurate, AI-powered automatic analysis and diagnosis of 12-lead resting ECGs. This tool is ideal for rapidly identifying conditions like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, assisting physicians in general cardiology, emergency medicine, or internal medicine settings.

View AI-ECG Platform →

Choose Viz RV/LV if…

Choose Viz RV/LV if your focus is on rapid and automated risk stratification for suspected pulmonary embolism using CTPA scans. This AI algorithm excels at precisely measuring the right and left ventricular diameters to calculate the RV/LV ratio, facilitating quick clinical decisions and enhanced care coordination within a PE response workflow.

View Viz RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Platform Viz RV/LV
Deployment On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client). Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Tool B, Viz RV/LV, is cloud-based and offers a high-fidelity mobile DICOM image viewer, enhancing accessibility and flexibility for clinicians on the go. Its integration with AI-powered alerts and a HIPAA-compliant communication platform also streamlines care coordination, contributing to a more intuitive and collaborative user experience.

Clinical Value

Tie

Both tools are FDA-cleared, indicating validated clinical utility in their respective domains. Tool A provides broad, high-accuracy ECG analysis for multiple cardiac conditions, while Tool B offers crucial, automated RV/LV ratio measurements for time-sensitive pulmonary embolism risk stratification. Both address significant clinical needs effectively within their specialized areas.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly available pricing information, requiring direct contact with the vendors for quotes. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Viz RV/LV

Tool B explicitly states its HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical requirements for enterprise healthcare deployments. While Tool A states these are 'likely,' the lack of explicit confirmation poses a potential hurdle for enterprise adoption, giving Tool B a clear advantage in documented readiness.

Innovation

Viz RV/LV

While both leverage AI, Tool B's innovation extends beyond automated measurement to include intelligent care coordination, AI-powered alerts, and seamless integration within the broader Viz PE Solution. This holistic approach to disease management, combining diagnosis with workflow optimization and communication, demonstrates a more comprehensive and advanced application of AI.

Support & Docs

Tie

The provided structured facts do not contain any specific information regarding the availability, scope, or quality of support services or documentation for either Tool A or Tool B. Without these details, it is not possible to differentiate between the two products on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Platform Viz RV/LV
Name AI-ECG Platform Viz RV/LV
Company Shenzhen Carewell Electronics Co., Ltd. Viz.ai
Primary Analysis Focus Automatic analysis and diagnosis system for 12-lead resting ECG Automates right and left ventricular diameter measurements from CTPA scans
Key Measurements/Outputs Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; professional ECG review, waveform measurement, and report generation Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; annotated images showing ventricular measurements; AI-powered alerts and notifications
Supported Data Formats Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG High-fidelity mobile DICOM image viewer (implies DICOM support)
Specialties Cardiology, Emergency Medicine, Internal Medicine Emergency Medicine, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Platform and Viz RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Platform by Shenzhen Carewell Electronics is designed to assist physicians in interpreting 12-lead resting ECGs for conditions such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. Viz RV/LV by Viz.ai automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification.
The AI-ECG Platform analyzes 12-lead resting ECG data and is compatible with various ECG data formats, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG. Viz RV/LV processes volumetric CTPA acquisitions to identify and measure heart ventricles.
The AI-ECG Platform provides automatic analysis and diagnosis of major cardiovascular diseases with over 95% accuracy, including arrhythmias and myocardial ischemia. Viz RV/LV delivers an automated right ventricle (RV) to left ventricle (LV) ratio measurement and annotated images showing ventricular measurements.
For the AI-ECG Platform, HIPAA compliance and a BAA are likely but not explicitly stated on its public website. Viz RV/LV explicitly states it is HIPAA compliant and has a BAA.
The AI-ECG Platform is designed to support Cardiology, Emergency Medicine, and Internal Medicine. Viz RV/LV primarily supports Emergency Medicine, Pulmonology, and Radiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.